Munapsys was designed to target the damaging effects of skin glycation. Glycation is a chemical process in which sugars react with proteins in the skin, resulting in loss of elasticity, wrinkles, and dull appearance of the skin.

Munapsys was developed to block the negative effects of glycation by limiting the formation of advanced glycation end products (AGEs) and inhibiting RAGE receptors (advanced glycation end product receptors). Helping to improve the appearance of the skin and minimize the signs of aging linked to glycation.